Bausch + Lomb Corporation Common Shares (BLCO) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Bausch + Lomb Corporation Common Shares (BLCO) is Neutral.

The composite score behind that read is +0.03, weighing +0.17 of bullish evidence against -0.24 bearish.

Bausch + Lomb Corporation Common Shares last closed at $17.17, +0.35% on the session.

Against the IVW growth benchmark the position is -0.57% over the forecast window.

The read is built from 12 underlying insights — 8 bullish and 4 bearish.

Agreement across those insights is 67%.

Bausch + Lomb Corporation Common Shares has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Bausch + Lomb Corporation Common Shares in the 37th percentile on return on equity, where 100 is best.

Bausch + Lomb Corporation Common Shares is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $6.11B.

StockMap tracks Bausch + Lomb Corporation Common Shares as the 27th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite Bausch + Lomb Corporation Common Shares ranks 3rd of 133 in the group, against a group median of -0.21.

Other Health Care stocks

Bausch + Lomb Corporation Common Shares (BLCO) — StockMap 2-week forecast & tracked accuracy